The goal of this grant application is development of methods for understanding the consequences of antiretroviral treatment for the development of antiviral resistance. The development of resistance results from the acquisition of mutations over time-a process that both reflects and contributes to amount of replicating virus and perhaps also the fitness of virus. We intend to model these process jointly to study the complex co-evolution of viral genotype and such longitudinal measures as viral load or fitness, and CD4 count. Specifically our aims are: 1) Inclusion of time-varying covariates in hidden Markov models of viral genetic progression to examine the impact of viral diversity, viral load, and other factors on pathways to antiviral resistance. 2) Joint modeling of genetic pathways to resistance (using hidden Markov models) and time to virological failure, in settings where the genetic state is know with error. 3) Semiparametric methods for relating viral genotype to phenotype and to investigate the impact of specific mutations in the presence of others. 4) U-statistic approaches for two group comparisons of repeated measures of viral load, when times of measurement are arbitrary. 5) Assessing surrogacy of high-dimensional longitudinal markers subject to measurement error and missingness.
Aim 1) investigates how factors like viral load, treatment, adherence history or other time-varying factors influence the pathways to resistance taken by the virus.
Aim 2) investigates the influence of genetic pathway on the time course of longitudinal measures, like viral load or fitness.
Aim 3) extends the methods developed in the last grant period to relate genotype to any response variable. The new methods are semi parametric; they should be more robust to nonnormality of errors and more powerful than the previous methods.
Aim 4) arose from consideration of the problems raised in an AIEDRP concept sheet to investigate the impact of primary resistance mutations on the virological response to treatment.
Aim 5) investigates the degree to which information on short-term response of viral load and on acquisition of resistance mutations can serve as surrogates for longer term clinical outcomes. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI051164-05
Application #
7024538
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Gezmu, Misrak
Project Start
2002-03-01
Project End
2008-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
5
Fiscal Year
2006
Total Cost
$320,292
Indirect Cost
Name
Harvard University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Ogburn, Elizabeth L; Rotnitzky, Andrea; Robins, James M (2015) Doubly robust estimation of the local average treatment effect curve. J R Stat Soc Series B Stat Methodol 77:373-396
Carnegie, Nicole B; Goodreau, Steven M; Liu, Albert et al. (2015) Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role. J Acquir Immune Defic Syndr 69:119-25
Goyal, Ravi; De Gruttola, Victor; Blitzstein, Joseph (2014) Sampling Networks from Their Posterior Predictive Distribution. Netw Sci (Camb Univ Press) 2:107-131
Carnegie, Nicole Bohme; Wang, Rui; Novitsky, Vladimir et al. (2014) Linkage of viral sequences among HIV-infected village residents in Botswana: estimation of linkage rates in the presence of missing data. PLoS Comput Biol 10:e1003430
Tchetgen Tchetgen, Eric (2014) The control outcome calibration approach for causal inference with unobserved confounding. Am J Epidemiol 179:633-40
Wang, Rui; Goyal, Ravi; Lei, Quanhong et al. (2014) Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clin Trials 11:309-318
Wang, Rui; Weng, Jia; Moyo, Sikhulile et al. (2013) Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. AIDS Res Hum Retroviruses 29:901-6
Stephens, Alisa J; Tchetgen Tchetgen, Eric J; De Gruttola, Victor (2013) FLEXIBLE COVARIATE-ADJUSTED EXACT TESTS OF RANDOMIZED TREATMENT EFFECTS WITH APPLICATION TO A TRIAL OF HIV EDUCATION. Ann Appl Stat 7:2106-2137
Goyal, Ravi; Wang, Rui; DeGruttola, Victor (2012) Editorial commentary: network epidemic models: assumptions and interpretations. Clin Infect Dis 55:276-8
Lok, Judith J; DeGruttola, Victor (2012) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients. Biometrics 68:745-54

Showing the most recent 10 out of 50 publications